FindMyKOL
Clinical trialNCT00679263CompletedPhase 2Interventional

Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma

SponsorMediciNovaEnrollment17Asthma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety and tolerability of MN-221 at two different dosing rates administered through a continuous infusion in subjects diagnosed with moderate to severe asthma.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Pra International

    Lenexa, Kansas, United States

  • Northeast Medical Research Associates

    North Dartmouth, Massachusetts, United States

  • Clinical Research of the Ozarks

    Rolla, Missouri, United States

  • Greenville Pharmaceutical Research

    Greenville, South Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

MN-221Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Feb 2008
Primary completion
31 Jul 2008
Completion
31 Jul 2008
Last update posted
19 Dec 2011
Registered enrollment
17
Registry id
NCT00679263
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.